UnitedHealth’s $5B Volume Slides to 12th in U.S. Rankings as Shares Dip 1.45%

On August 20, 2025, UnitedHealth Group (UNH) closed down 1.45% with a trading volume of $5.0 billion, representing a 26.38% drop in activity compared to the previous day. The stock ranked 12th in total trading volume among U.S. equities.

Investor sentiment toward UnitedHealth has been shaped by strategic moves from high-profile figures. Warren Buffett’s Berkshire Hathaway acquired over 5 million shares of the insurer in Q2 2025, valued at approximately $1.6 billion. This followed a challenging period for the company, marked by a 50% decline in its stock price over the prior year. The investment has been interpreted as a vote of confidence amid operational hurdles, including unanticipated medical cost trends and regulatory scrutiny over Medicare billing practices.

The company faces significant challenges in aligning its pricing strategies with rising healthcare expenses. UnitedHealth reported a $6.5 billion overpayment in medical costs for 2025, driven by higher-than-expected utilization of services such as emergency room visits and behavioral health care. Its Medicare Advantage segment, in particular, is grappling with a 7.5% cost trend—far exceeding initial projections of 5%. Leadership changes, including the return of former CEO Stephen Hemsley, have been part of broader operational overhauls aimed at improving forecasting and cost management.

UnitedHealth’s strategic response includes leveraging artificial intelligence to enhance efficiency and adjust 2026 pricing models. However, regulatory constraints on Medicare pricing and systemic issues in U.S. healthcare, such as overreliance on emergency care, pose ongoing risks. Analysts suggest the company’s turnaround could take time, with near-term focus on stabilizing cost trends and restoring investor trust.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to now delivered moderate returns. The 1-day return was 0.98%, with a total return of 31.52% over 365 days. This indicates the strategy captured some short-term momentum but also reflected market volatility and potential timing risks.